| Aug 5 |
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 5 |
CRISPR Therapeutics GAAP EPS of -$1.49 beats by $0.05
|
| Aug 5 |
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
|
| Aug 4 |
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
|
| Aug 1 |
CRISPR Therapeutics AG (CRSP): Ark Invest is Bullish on This Stock Right Now
|
| Aug 1 |
Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Jul 31 |
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
|
| Jul 29 |
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
|
| Jul 29 |
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
| Jul 24 |
CRISPR Therapeutics Nears 52-Week Low. Time to Buy?
|
